×

Neville Registrars is delighted to welcome ACP Energy Plc as the newest addition to its list of client companies.

ACP Energy will focus on producing assets that are either in production or near production to ensure swift cash flow generation and stability to the business.

Further information can be found on the Company's website: https://acpenergyplc.com/

 

 

 

Close

×

RNS Number : 7773Z

Shearwater Group PLC

27 January 2022

 

27 January 2022
RNS Reach

Shearwater Group PLC
 

("Shearwater", or the "Group")
 

Contract Renewals

 

Brookcourt Solutions secures two contract renewals with a leading Global Financial Organisation

 

Shearwater Group plc (AIM: SWG), the organisational resilience group that provides cybersecurity, advisory and managed security services, is pleased to announce that its group company, Brookcourt Solutions, has secured two contract renewals with a leading Global Financial Organisation.

 

The first renewal, a one year contract totalling over $1.1m sees Brookcourt Solutions continuing to be the supplier of choice to support and deliver a complex security software solution; Real Time Visibility for big data, that will actively contribute to enhancing security and compliance within the organisation.

 

The second contract renewal, a 16 month contract has a value of c. £450k. The renewal, for Insider Threat Management Software, appoints Brookcourt Solutions to continue to support and assist in the delivery of this cyber security software that will actively contribute in helping the bank detect, investigate and prevent potential insider threat incidences with real-time alerts.

 

Under both of these contract renewals, Brookcourt Solutions services will actively support this global banking organisation enhance their organisational resilience and cyber security position.

 

Phil Higgins, Group Chief Executive Officer of Shearwater, commented:

 

"These contract renewals with a leading global financial organisation represent yet another endorsement of Shearwater as a supplier of choice able to continue to leverage and deploy our deep understanding of best-in-class technologies for clients in the financial sector, which recognises the rising importance of maintaining vigorous cyber and security operations."

 

 

Enquiries:

Shearwater Group plc David Williams Phil Higgins	www.shearwatergroup.com c/o Alma PR
Cenkos Securities plc – NOMAD and Joint Broker Ben Jeynes / Max Gould – Corporate Finance Julian Morse / Michael Johnson – Sales	+44 (0) 20 7397 8900
Berenberg – Joint Broker  Matthew Armitt / Mark Whitmore	+44 (0) 20 3207 7800
Alma PR Susie Hudson / Caroline Forde / Joe Pederzolli	[email protected]  +44 (0) 20 3405 0205

 

This is an RNS Reach announcement and the information contained is not considered to have a significant impact on management's expectations of the Group's performance. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

About Shearwater Group plc

 

Shearwater Group plc is an award-winning group providing cyber security, managed security and professional advisory solutions to help create a safer online environment for organisations and their end users.
 

The Group's differentiated full service offering spans identity and access management and data security, cybersecurity solutions and managed security services, and security governance, risk and compliance. Its growth strategy is focused on building a scalable group that caters to the entire spectrum of cyber security and managed security needs, through a focused buy and build approach.

The Group is headquartered in the UK, serving customers across the globe across a broad spectrum of industries.
 

Shearwater shares are listed on the London Stock Exchange's AIM under the ticker "SWG".  For more information, please visit www.shearwatergroup.com.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAKZGZMZVVGZZZ

Close

×

RNS Number : 4127Z

N4 Pharma PLC

25 January 2022

 

25 January 2022

N4 Pharma Plc

("N4 Pharma" or the "Company")

Oncology work programme update

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide details of its work plan following the encouraging data from its oncology research as announced on 13 December 2021.

The Board is delighted that the studies conducted with Nanomerics to evaluate the potential of Nuvec® as a nano-carrier of a DNA plasmid expressing TNFalpha ("TNF"), a cytokine with immune-modulating properties against tumours, demonstrated a significant inhibition of tumour growth derived from a human cell line.

As a result of these positive findings, the Company has commenced work with Medicines Discovery Catapult* ("Catapult") to extend the observations to allow it to identify suitable loads to add to Nuvec® to take to clinic. To date, the Company has established that Nuvec® can deliver an appropriate biological load and this new study will help determine the mechanism of action that produced the tumor suppression. Amongst other things, it will seek to identify whether the Nuvec® loaded with TNF alpha was directly taken up by the tumour cells to produce the active TNF within the tumour or whether other organs such as the liver took up the Nuvec® and produced the TNF and released it systemically to suppress the tumour. If it can be demonstrated that Nuvec® can selectively deliver the plasmid to the tumour this may indicate the potential use of Nuvec® to deliver to tumours with a reduced systemic effect and inform the scope of any clinical studies or collaboration discussions. In addition, studies will use labelled Nuvec® particles to allow the organ and tissue distribution of Nuvec® to be followed. 

The Company is also in the process of identifying alternatives to TNF as immunomodulators or gene therapy which may use Nuvec® as a delivery system. The selection process is expected to conclude shortly and the Company intends to conduct a study programme similar to the work being undertaken using TNF.

 

All current and planned work streams are to be funded from existing resources and the Company remains well funded for 2022.

Nigel Theobald, Chief Executive Officer of the Company, commented : " We are delighted that our successful work in formulating Nuvec® as a monodispersed formulation that can be freeze dried and reconstituted has opened up the opportunity for the Company to use Nuvec® via intravenous injection and to develop products using Nuvec® as a nano-carrier of nucleotides including DNA, RNA, SiRNA with specific clinical use in oncology, gene therapy and protein replacement.

"The oncology, gene therapy and protein replacement markets are very large and attracting significant and varied interest.  Based on our current data, these markets provide the Company with the quickest route to bring products into clinical trials, far quicker than using it for vaccines. With our vaccine work now continuing through MTAs, our primary focus is on these studies with Catapult and advancing our data set to a meaningful inflexion point in the coming months and I look forward to providing updates to the market in due course."

* The Medicines Discovery Catapult is a government funded, not-for-profit organisation established by  Innovate UK  to support UK innovation. The Catapult Network brings together nine leading technology and innovation centres spanning over 40 locations across the UK. Catapults are physical centres with cutting-edge R&D infrastructures including hubs, laboratories, testbeds, factories and offices, as well as technical experts that prove and adopt breakthrough products, processes, services and technologies.

Catapults work with thousands of innovative businesses across a wide range of sectors, such as manufacturing, space, health, digital, energy, transport, telecoms, the urban environment and many others to help industry get high potential ideas to market – fuelling business growth, and increasing productivity. 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. 

Enquiries:

N4 Pharma Plc Nigel Theobald, CEO Luke Cairns, Executive Director	Via IFC Advisory
SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Caroline Rowe (Corporate Finance) Vadim Alexandre/Rob Rees (Corporate Broking)	Tel: +44 (0)20 3470 0470
Turner Pope Investments (TPI) Limited Joint Broker Andy Thacker	Tel: +44 (0)20 3657 0050
IFC Advisory Limited Financial PR Graham Herring Zach Cohen	Tel: +44 (0)20 3934 6630

 

 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCSEIFDLEESEEF

Close

×

RNS Number : 2949Z

Croma Security Solutions Group PLC

24 January 2022

 

24 January 2022

 

CROMA SECURITY SOLUTIONS GROUP PLC

("CSSG" or the "Company")

 

NEW STRATEGIC PARTNERSHIP

 

Croma Security Solutions Group Plc, the total security services provider, is pleased to announce that it has entered into a new strategic partnership with FinGo, a biometric identity authentication and payments platform. The new alliance will complement and strengthen each company's leading solutions in the provision of non-invasive biometric technology.

 

Croma currently deploys FASTVEIN™ biometrics across the education and construction sectors, providing customers with a quick, easy to use, accurate and cost-effective identity management. Working with FinGo will allow Croma to expand its product suite to include payments alongside existing identity and access control offerings in these sectors. This partnership will also expand FinGo's digital identity management and payment expertise to include access management.

 

Over the last 12 months, FinGo has adapted its solutions to integrate with COVID-support services, including secure contact tracing within hospitality settings and verification of employee COVID test results within the care industry. The company is also in talks with policy makers over the use of FinGo and vein ID for vaccine certification.

 

Nick Dryden, FinGo Chief Executive Officer, commented " FinGo is delighted to enter into this strategic partnership with Croma. The combined capability, coupling many years of experience in the security and access management arena with our payments and digital identity management expertise, will create a unique offering. We look forward to taking the joint offering to market in 2022 and giving existing and new customers an opportunity to deploy one single secure and convenient biometric solution."

 

Roberto Fiorentino, Chief Executive Officer, Croma, added: "Croma is very pleased to announce today our official partnership with FinGo. This collaboration will give rise to the sharing of resource and solutions to bring exacting client offerings across a number of verticals in which we each currently operate. We are excited about the opportunity of building on our position in the provision of human identification, biometric payment systems and access control solutions."

 

Sebastian Morley, Chairman, Croma, said " We are delighted to announce this strategic partnership. 

This is a clear direction of travel post COVID when credible service providers are seeking to collaborate in order to deliver for clients and shareholders."

 

  

ENDS

 

 

For further information visit www.cssgroupplc.com or contact:

 

Croma Security Solutions Group Plc  Tel: +44 (0)7768 006 909

Sebastian Morley (Chairman)

 

WH Ireland Limited                                                                                      Tel: +44 (0)207 220 1666

(Nominated Adviser and Broker)

Mike Coe

Jessica Cave

 

Novella                                                                                                            Tel: +44 (0)203 151 7008

Tim Robertson

Fergus Young

 

 

About FinGo 

FinGo is the world's first biometric identity authentication solution, open to everyone and a mission to provide a more secure and inclusive way to navigate the world. FinGo uses unique vein patterns hidden inside a finger to instantly identify and authenticate individuals without the need for cards or devices to be present. 

 

Originally payments focused, parent company Sthaler Ltd was founded from a desire to create a cashless experience for festivals and events, with FinGoPay introduced at Festival No 6.  Recent awards include Fast Company: Top 10 Europe's Most Innovative Companies, 2020; UK Enterprise Awards: Identity Servicer Product Innovator of the Year, 2020; Syndicate Room: Top 100 Fastest Growing UK Companies 2019; Telegraph: Smart City Innovation Award Industry Innovation of the Year, 2019 and Restaurant TECH Live: Tech Product of the Year, 2018. 

www.fingo.to

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCUARWRUKUAUAR

Close

×

RNS Number : 2298Z

Pennant International Group PLC

21 January 2022

 

 

 

FOR IMMEDIATE RELEASE                                                    21 January 2022  

 

PENNANT INTERNATIONAL GROUP PLC

 

Major Programme Update

 

Pennant named as key supplier by Boeing Defence United Kingdom

 

 

Pennant International Group plc (AIM:PEN)("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, provides the following update.

 

The Group is pleased to note that it has been named as a key supplier in this morning's announcement by Boeing Defence United Kingdom Limited (BDUK) regarding the award of the long-term services contract for the UK's new Apache helicopter fleet.

 

Pennant's scope of work will be to deliver several new and upgraded Part Task Trainers which are compatible with the new fleet (this being referred to in prior announcements as the 'Major Programme'). Pennant and BDUK are presently working to finalise Pennant's contract and award is expected imminently.

 

The Group looks forward to working with BDUK to deliver this important capability to UK Defence.

 

The BDUK press release may be viewed here:

 

https://www.boeing.co.uk/news-media-room/news-releases/2022/january/boeing-expands-uk-military-support-with-apache-ah-64e.page  

 

  Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc	www.pennantplc.co.uk
Philip Walker, CEO David Clements, Commercial & Risk Director	+44 (0) 1452 714 914
WH Ireland Limited (Nomad and Broker)	www.whirelandcb.com
Mike Coe Sarah Mather	+44 (0) 20 7220 1666
Walbrook PR (Financial PR)	[email protected]
Paul Vann Tom Cooper	+44 (0)20 7933 8780 Mob: +44 (0)7768 807631

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDBBMMTMTBTBIT

Close

×

RNS Number : 0223Z

Silver Bullet Data Services Grp PLC

20 January 2022

 

20 January 2022

 

Silver Bullet Data Services Group plc

("Silverbullet" or the "Company", or, together with its subsidiaries, the "Group")

 

Contract Wins and Sub-Contract Wins through Salesforce Partnership

 

 

Silverbullet, a provider of digital transformation services and products, is pleased to announce a number of recent Group contract wins and general marketing services projects, as well as several sub-contract wins through its partnership with Salesforce. These contracts are expected to generate combined sales of approximately £425,000 during 2022.

 

GENERAL MARKETING SERVICES PROJECTS 

 

Haier Europe

Silverbullet, through its partnership with Local Planet, now supports Haier Europe (part of Haier Smart Home,) to optimise their adtech and martech infrastructures. The project is aimed to highlight the main opportunities for growth, improve processes and governance, unlock the potential of data and drive use cases. Silverbullet have been assigned to develop and deliver a detailed assessment and gap analysis, with the goal of incrementally enhancing the client's data-driven advertising and marketing.

 

Global consumer-packaged goods company

Silverbullet has expanded its partnership with one of its longest-standing clients in the US market. Silverbullet's US-based consulting team will support the consumer-packaged goods ("CPG") organisation and all brands within its portfolio via a year-long retainer to design, develop and execute its consumer data strategy. This includes collection, enrichment and cross channel activation across multiple touch points. This latest assignment further cements the trust, based long-term partnership, between this global CPG organisation and Silverbullet Data Services.

 

Financial Services company

Silverbullet is working with a financial services client to allow them to run high-standard data-driven marketing activities in a cookie-less world. In particular, Silverbullet will support the client in the centralisation of the management of data, use cases and martech systems.

 

 

SALESFORCE PARTNERSHIP 

 

Sub-contract wins through Salesforce partnership

Silverbullet has won a number of sub-contract wins through its partnership with Salesforce. Silverbullet has further expanded its partnership with Salesforce, scaling up campaign delivery for Salesforce customers across its 'Marketing Cloud' solutions. Silverbullet are the chosen partner to work alongside the Salesforce campaign delivery team supporting a leading global lingerie, clothing, and beauty retailer and a multinational conglomerate company. Silverbullet will leverage its expertise in coding, building content, email testing and rendering across the Salesforce 'Marketing Cloud', feeding into the delivery of multi-variant emails across numerous markets.

 

Furthermore, Silverbullet was engaged to implement Salesforce 'Marketing Cloud' and 'Interaction Studio' for a media and journalism company based in Australia. After the initial phase of work, this client has engaged Silverbullet to complete additional use cases to drive value from the platform which is on a pay as you go basis.

 

Ian James, Chief Executive Officer of Silverbullet, commented:

"We are delighted to have secured these contract wins, which reflect the satisfaction and fulfilment of our clients' needs through the unique capability and expertise we offer in this highly specialist area.

 

"Additionally, we are extremely pleased to be a trusted partner to Salesforce, who we have had a long-standing four-year relationship with. We are trusted to deliver our services, knowledge and capability to their clients through our leading digital transformation services and products. We are continuing to pick up real global momentum and look forward to providing further updates in due course."

 

 

For further information please contact:

 

Silverbullet	via IFC
Ian James (CEO)
Strand Hanson Limited – Financial and Nominated Adviser	0207 409 3494
James Spinney / James Bellman
Oberon Capital – Broker	0203 179 5344
Mike Seabrook / Robert Hayward
IFC Advisory	020 3934 6630
Graham Herring / Tim Metcalfe / Florence Chandler	07793 839 024

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

About Silverbullet

Silverbullet's proprietary 4D advertising solution is designed to help advertisers target consumers in a "post cookie world". The product is a natural extension to its existing services business which already serves a blue-chip client base such as Heineken, Channel 4, Amazon, ITV and Jägermeister amongst many others.

 

The removal of third-party cookies has already been implemented by web browsers such as Firefox and Safari, with Google expected to phase out the use of cookies in 2022. 

Headquartered in London, the Group employs 66 employees across five regions across the globe, including, the UK, Italy, Germany, Australia and the US. The Group continues to look at other opportunities for expansion worldwide.

The Company has an established and growing services business with significant accumulated industry experience and a proven track record of delivering strategic projects and activation services to its clients.

The majority of the Board have held senior positions at global software companies and have significant industry experience across data engineering, SAAS product development and marketing.

The Group has close technical and commercial partnerships with Salesforce, Oracle and Adobe, all of which have existing sales channels and are already delivering to clients.

The Group has established a joint venture and strategic partnership with Local Planet, a scaled network of over 60 agencies across the globe which transact, in aggregate, over US$16 billion of media buying on behalf of their clients. The Local Planet joint venture, established in December 2020, which has already generated material services revenues for the Group, presents a significant opportunity to provide further data services and the 4D product to the Local Planet agency network.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTFFFLLLEIALIF

Close

×

RNS Number : 5416Y

4GLOBAL PLC

17 January 2022

 

17 January 2022

4GLOBAL PLC

("4GLOBAL" or the "Company")

Launch of new Social Value Calculator

4GLOBAL, a UK-based data, services and software company focused on major sporting events and the promotion and measurement of physical activity, is pleased to announce the launch of the latest version of its Social Value Calculator ("SVC").

4GLOBAL's SVC is designed to give leisure providers a tool to measure and provide evidence of the social value created from investment in sport and physical activity. Social value encompasses health, wellbeing, educational and social benefits experienced by people, communities and society generally through physical activity.

The SVC is a fundamental element in 4GLOBAL's business model, in use since the Company's inception, and enables clients to calculate an estimate of the monetary value arising from investment.

The new version uses a duration-based model with a focus on the amount of time per week people spend engaged in physical activity. The model now extends to include those who are less active rather than the previous focus on the more active only. The new version of the SVC also enables clients to assess the financial benefits arising from improvements in physical and mental health, subjective wellbeing, individual development and social and community development. Users can apply a range of filters to focus on specific outcomes or target groups which are key to their investment decisions.

4GLOBAL's SVC is already widely used by its clients to assess the financial impact of health and wellbeing initiatives. The Directors believe that the new SVC will provide 4GLOBAL's clients with the tools to make even more compelling cases for new contracts and will strengthen further 4GLOBAL's unique selling proposition and enhance new business conversions.

Eloy Mazon, Chief Executive Officer of 4GLOBAL, commented:

"Our new SVC (v3) is part of our ongoing programme of upgrades to assist clients in making investment decisions and helping them assess whether their investments are achieving the criteria set for them. 

 

"We are delighted that all 4GLOBAL's existing clients are migrating to the new product. Also encouragingly, additional new clients are already showing interest and are attracted by the enhanced offering. 

 

"Our aim is to lead the high growth market in which we operate providing clients with highly functional tools to assess and monitor projects. With our committed team, unique database and market leading analytical tools, I believe we can look forward optimistically to an exciting future for 4GLOBAL."

 

For further information please contact:

4GLOBAL		c/o IFC Advisory
Eloy Mazon (CEO)
Spark Advisory Partners – Nominated Adviser		0203 368 3554
Neil Baldwin
Oberon Capital – Broker		0203 179 5300
Michael Seabrook, Robert Hayward, Chris Crawford
IFC Advisory		0203 934 6630
Graham Herring / Zach Cohen		07793 839 024

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAGPURAGUPPGQC

Close

×

Neville Registrars are delighted to welcome Hop Back Brewery Plc as the newest addition to its list of client companies.

Hop Back Brewery have been brewing award winning beer since 1987.

Further information can be found on the Company's website https://www.hopback.co.uk/ 

Close

×

RNS Number : 1253Y

Image Scan Holdings PLC

12 January 2022

 

The information contained within this announcement is deemed to constitute inside information as  stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

12 January 2022

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

LAUNCH OF NEW PORTABLE X-RAY SYSTEM

 

Image Scan, (AIM: IGE) specialists in the field of X-ray imaging for the security and industrial inspection markets, announces the market launch of the ThreatScan®-AS1 integrated portable X-Ray system for bomb squads and security professionals worldwide. Private demonstrations have already been carried out, and the system will be shown to the wider security community for the first time at the upcoming Intersec exhibition in Dubai.

The new system is the first to use an amorphous silicon detector panel, the same technology used in medical X-ray. Additionally, the system is highly integrated, with the primary display, computer, communications and power supplies fully integrated into a single, rugged case. With the addition of secondary tablet display, ThreatScan®-AS1 offers high flexibility in deployment to meet a wide variety of threat scenarios.

The system also incorporates a new, higher energy, version of the Company's I-Gen portable X-ray generator.

The combination of technologies used in ThreatScan®-AS1offers exceptional X-ray imaging performance, advanced material discrimination, and Image Scan's sophisticated image processing software.  

Bill Mawer, Executive Chairman of Image Scan commented: "I am delighted to announce the launch of this important new system. Amorphous Silicon is a complementary technology to our highly successful linescan detectors and will allow us to offer a wide range of system configurations to meet customers' individual operating requirements, technology preferences and budgets. It is a testimony to the work of our entire team that this system has been conceived, developed, and transferred to production during the pandemic."

 

For further information on the Company, please visit:   www.ish.co.uk   and for further information on its products, please visit:   www.3dx-ray.com

 

Enquiries:
Image Scan Holdings plc William Mawer, E xecutive Chairman Sarah Atwell King, Finance Director and Company Secretary	Tel: +44 (0) 1509 817 400 [email protected]
W H Ireland – Nominated Adviser and Broker Mike Coe/Sarah Mather (Corporate Finance)	Tel: +44 (0)20 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCFLFFDLIILLIF

Close

×

RNS Number : 9889X

Shearwater Group PLC

11 January 2022

 

11 January 2022
RNS Reach

Shearwater Group PLC

("Shearwater", or the "Group")

Contract Win

Pentest Limited secures new contract win with a global technology business

Shearwater Group plc, the organisational resilience group that provides cybersecurity advisory and managed security services, announces that its group company, Pentest Limited, has secured a significant new contract with a global technology business worth £300,000. The majority of the contract's value is expected to be realised in the current full year and the contract contributes to the Group's current full year expectations.

Under the terms of this contract, Pentest will deliver a range of vulnerability assessment and penetration testing services to the business, in relation to a major new project. Pentest will perform an in-depth investigation into the organisation's resilience, with the continued aim of uncovering any IT security vulnerabilities by simulating the actions of a threat actor.

Phil Higgins, Chief Executive Officer of Shearwater Group plc, commented:

"Successfully securing such a contract win with a global technology organisation highlights the recognition of both Pentest and the wider Group, as well as the quality and appeal of our offering. We take great pride in being awarded opportunities of this nature, allowing the group to positively contribute towards evaluating and improving an organisation's security and resilience."

Enquiries:

Shearwater Group plc David Williams Phil Higgins	www.shearwatergroup.com c/o Alma PR
Cenkos Securities plc – NOMAD and Joint Broker Ben Jeynes / Max Gould – Corporate Finance Julian Morse / Michael Johnson – Sales	+44 (0) 20 7397 8900
Berenberg – Joint Broker  Matthew Armitt / Mark Whitmore	+44 (0) 20 3207 7800
Alma PR Susie Hudson / Caroline Forde / Joe Pederzolli	[email protected]  +44 (0) 20 3405 0205

 

This is an RNS Reach announcement and the information contained is not considered to have a significant impact on management's expectations of the Group's performance. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

About Shearwater Group plc

Shearwater Group plc is an award-winning group providing cyber security, managed security and professional advisory solutions to help create a safer online environment for organisations and their end users.

The Group's differentiated full service offering spans identity and access management and data security, cybersecurity solutions and managed security services, and security governance, risk and compliance. Its growth strategy is focused on building a scalable group that caters to the entire spectrum of cyber security and managed security needs, through a focused buy and build approach.

The Group is headquartered in the UK, serving customers across the globe across a broad spectrum of industries.

Shearwater shares are listed on the London Stock Exchange's AIM under the ticker "SWG".  For more information, please visit www.shearwatergroup.com.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRABKKBQOBKDFDD

Close